Unknown

Dataset Information

0

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.


ABSTRACT: The term "idiopathic erythrocytosis (IE)" is applied to those cases where a causal clinical or pathological event cannot be elucidated and likely reflects a spectrum of underlying medical and molecular abnormalities. The clinical course of a patient with IE is described manifesting as a persistent erythrocytosis with a low serum erythropoietin level, mild eosinophilia, and with evidence of a thrombotic event. The patient subsequently developed a myelodysplasic syndrome (MDS) and acute myeloid leukemia (AML), an event not observed in erythrocytosis patients other than those with polycythemia vera (PV). Application of a next-generation sequencing (NGS) approach targeted for myeloid malignancies confirmed wild-type JAK2 exons 12-15 and identified a common SH2B3 W262R single-nucleotide polymorphism associated with the development of hematological features of myeloproliferative neoplasms (MPNs). Further NGS analysis detected a CBL L380P mutated clone expanding in parallel with the development of MDS and subsequent AML. Despite the absence of JAK2, MPL exon 10, or CALR exon 9 mutations, a similarity with the disease course of PV/MPN was evident. A clonal link between the erythrocytosis and AML could be neither confirmed nor excluded. Future molecular identification of the mechanisms underlying IE is likely to provide a more refined therapeutic approach.

SUBMITTER: Langabeer SE 

PROVIDER: S-EPMC5842720 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.

Langabeer Stephen E SE   Conneally Eibhlin E   Flynn Catherine M CM  

Case reports in hematology 20180222


The term "idiopathic erythrocytosis (IE)" is applied to those cases where a causal clinical or pathological event cannot be elucidated and likely reflects a spectrum of underlying medical and molecular abnormalities. The clinical course of a patient with IE is described manifesting as a persistent erythrocytosis with a low serum erythropoietin level, mild eosinophilia, and with evidence of a thrombotic event. The patient subsequently developed a myelodysplasic syndrome (MDS) and acute myeloid le  ...[more]

Similar Datasets

| S-EPMC6981810 | biostudies-literature
| S-EPMC6071325 | biostudies-literature
| S-EPMC3184204 | biostudies-literature
| S-EPMC2635399 | biostudies-literature
| S-EPMC3446943 | biostudies-literature
| S-EPMC6058791 | biostudies-literature
| S-EPMC8759124 | biostudies-literature
| S-EPMC6436966 | biostudies-literature
| S-EPMC4551362 | biostudies-literature
| S-EPMC10002503 | biostudies-literature